Dr. Michael McQueen presents "Two NICU Tools in Light of New Studies--the efficacy of nCPAP with a gentler interface". In this course you'll learn about:
- Discuss High Velocity Therapy
- Describe the differences between high velocity therapy and high flow nasal cannula (HFNC)
- Discuss how high velocity therapy is a viable alternative to nCPAP for primary respiratory support in neonates
- Understand that the FDA distinguishes between HFNC and high velocity therapy products
Author Bio
Michael C. McQueen MD, MBA, FAAP, has over 28 years of clinical and leadership experience. He has served as Regional Medical Director for Envision Healthcare, Medical Director of the NICU at Phoenix Children’s Hospital, as well as several NICUs within the Banner Healthcare System in Phoenix. He has also served as Regional President for Pediatrix Medical Group, and President of Obstetrix Medical Group. Dr. McQueen completed his Pediatric Residency at Phoenix Children’s Hospital / Maricopa Medical Center in Phoenix, AZ, and his Neonatal-Perinatal Medicine Fellowship at the University of Vermont, Burlington, VT. His recent contributions on High-Velocity Nasal Insufflation respiratory support in neonates can be found in J Pulm Respir Med (2014), J Health Economics and Outcomes Research (2015), and J Perinatology (2017). Dr. McQueen is currently Vice President of Medical Affairs at Vapotherm, Inc.
Course Curriculum
Frequently Asked Questions
- When does the course start and finish?
- A: The course starts now and never ends! It is a completely self-paced online course - you decide when you start and when you finish.
- How long do I have access to the course?
- How does lifetime access sound? After enrolling, you have unlimited access to this course for as long as you like - across any and all devices you own.